In emerging markets like South Africa, private healthcare inflation has historically outpaced general consumer inflation. One common response from the private sector has been continued investment in standalone hospital infrastructure, based partly on the expectation that expanding capacity would improve efficiency and meet growing demand. However, evidence suggests that adding expensive infrastructure to a fragmented healthcare system does not necessarily reduce costs; instead, it may introduce additional high-overhead facilities whose costs are ultimately borne by patients and medical schemes.
At RH Bophelo, our operating philosophy is guided by the principle of Capital That Heals. But in a macroeconomic environment characterised by constrained consumer spending and high interest rates, true healing must extend beyond clinical outcomes to include financial stability. Healthcare cannot heal if the patient cannot afford to access it.
Achieving this requires a critical evaluation of how healthcare capital is deployed. The most viable pathway to curbing spiralling costs may not lie in laying more bricks and mortar, but in the intelligent integration of the healthcare value chain. We view this through the lens of smart consolidation.
The “Fragmentation Tax” on Private Healthcare
To understand how consolidation would lower costs, one must first examine the mechanics of why care remains expensive. The private healthcare model is highly siloed. A patient visits a physician at one facility, travels to an independent laboratory for diagnostics, goes to a separate pharmacy to fill a prescription, and perhaps visits a standalone centre for chronic treatment, such as dialysis.
Each of these touchpoints represents an isolated business entity with its own administrative overheads, procurement inefficiencies, and profit margins. This represents what we could call a “fragmentation tax.” It is a structural inefficiency that directly depletes medical scheme benefits and increases out-of-pocket expenditure for the lower-middle-income demographic.
To meaningfully reduce the cost of care, capital allocators must actively look for ways to dismantle these silos. The objective is to engineer an ecosystem where these fragmented services are brought under a unified operational umbrella.
The Economic Mechanics of Consolidation
At RH Bophelo, we have systematically explored moving away from isolated infrastructure investments towards integrated high-utilisation, specialised services. Our strategy centres on partnering with co-location laboratories, pharmacies, and dialysis centres, as well as primary and acute care facilities, including our investment in Fountain Hospital.
This approach is rooted in basic mechanics. Consider pharmacy networks that process thousands of scripts each month across multiple sites. By consolidating this volume, an investment holding company transitions from being a passive participant in the supply chain to an entity with significant procurement leverage. High-volume aggregation creates the necessary conditions for aggressive negotiation with pharmaceutical manufacturers and distributors, which can, in theory, drive down the unit cost of medication.
A similar logic applies to diagnostics and chronic care. By integrating laboratories and dialysis centres into a broader ecosystem, administrative and logistical overheads can be shared across a wider revenue base. Operational risk is mitigated, and the resulting cost efficiencies can be embedded directly into the pricing structure offered to the end-user.
Refining the Bargaining Table
Perhaps the most significant potential benefit of smart consolidation is how it changes the dynamic between healthcare providers and medical schemes.
Medical schemes are inherently risk-conscious because their long-term sustainability depends on protecting the integrity of their risk pools. When operating within fragmented provider environments, schemes often face unpredictable billing patterns and reduced visibility into the total episodic cost of patient care, making cost management more complex.
By consolidating pharmacies, laboratories, and chronic care services, providers can offer medical schemes more efficient and predictable care-delivery value chains. Managing high patient volumes across integrated care touchpoints creates the scale needed to negotiate from a position of strength. Importantly, this leverage does not necessarily have to translate into higher tariffs. Instead, it enables consolidated networks to participate in alternative reimbursement arrangements, including capitation models and preferred provider networks, where providers accept predictable, often lower reimbursement structures in exchange for patient volume, continuity of care, and long-term contractual stability.
This model has the potential to create a mutually beneficial alignment: the medical scheme preserves its funds, the healthcare provider secures resilient cash flows in a sector characterised by perpetual demand, and most importantly, the patient’s benefits stretch further.
Architecting a Sustainable Future
The private healthcare sector is at an inflation point. The traditional playbook of capital-heavy, fragmented hospital development is rapidly reaching the ceiling of consumer affordability. If the industry is to expand access to quality healthcare for a broader demographic across South Africa, the underlying business model must evolve.
Capital deployment in healthcare should no longer be viewed simply as the financing of physical infrastructure. Increasingly, it shapes the structure and incentives of the healthcare system itself. When investment is directed toward consolidating services, reducing duplication, and achieving economies of scale, capital becomes more than a funding mechanism; it becomes a tool for improving systemic efficiency and coordination.
Smart consolidation demonstrates that operational efficiency and clinical excellence can be entirely interdependent. By integrating the spaces where patients are diagnosed, medicated, and treated, the industry can begin to strip excess out of the system. This is the essence of Capital That Heals: investments designed not only to treat the patient but also to target inefficiencies in the system they rely on.
